Intensive Care Management of a Parturient with Glanzmann’s Thrombasthenia: A Case Report

Authors

  • Abdelrady S. Ibrahim Anesthesia and ICU Department, Assiut University Hospital, Assiut, Egypt
  • Ahmed A. Sedek Anesthesia and ICU Department, Sabah Maternity Hospital, Kuwait
  • Tharwat M. Habib Anesthesia and ICU Department, Mansoura University Hospital, Mansoura, Egypt
  • Mayada A. Goda Anesthesia and ICU Department, Sabah Maternity Hospital, Kuwait
  • Tarek A. Assem 4Obstetrics and Gynecology Department, Sabah Maternity Hospital, Kuwait
  • Asmaa A Osman Clinical Pathology Department, Sabah Maternity Hospital, Kuwait
  • Waleed S. Farrag Anesthesia and ICU Department, Assiut University Hospital, Assiut, Egypt

DOI:

https://doi.org/10.31907/2310-9394.2020.08.03

Keywords:

Glanzmann's thrombasthenia, Pregnancy, Hemorrhage, Thrombocytopenia.

Abstract

Twenty-nine years old primigravida with a diagnosis of type 1 Glanzmann's thrombasthenia planned for labour induction was admitted to Intensive Care Unit for close observation, pain management and correction of any anticipated bleeding.

References

Stevens, R.F. and S. Meyer, Fanconi and Glanzmann: the men and their works. 2002. 119(4): p. 901-904. https://doi.org/10.1046/j.1365-2141.2002.03812.x

Braunsteiner, H. and F.J.B. Pakesch, Thrombocytoasthenia and thrombocytopathia— old names and new diseases. 1956. 11(11): p. 965-976. https://doi.org/10.1182/blood.v11.11.965.965

Caen, J., et al., Congenital bleeding disorders with long bleeding time and normal platelet count: I. Glanzmann's thrombasthenia (report of fifteen patients). 1966. 41(1): p. 4-26. https://doi.org/10.1016/0002-9343(66)90003-9

George, J.N., J.P. Caen, and A.T.J.B. Nurden, Glanzmann’s thrombasthenia: the spectrum of clinical disease. 1990. 75(7): p. 1383-1395.

Botero, J.P., et al., Glanzmann thrombasthenia: genetic basis and clinical correlates. 2020. 105(4): p. 888-894. https://doi.org/10.3324/haematol.2018.214239

Wijemanne, A., I. Watt-Coote, and S.J.O.M. Austin, Glanzmann thrombasthenia in pregnancy: optimising maternal and fetal outcomes. 2016. 9(4): p. 169-170. https://doi.org/10.1177/1753495x16655021

Hamamy, H.J.J.o.c.g., Consanguineous 19 International Journal of Anesthesiology Research, 2020, Vol. 8 Abdelrady S. Ibrahim et al. marriages. 2012. 3(3): p. 185-192. https://doi.org/10.1007/s12687-011-0072-y

Pavord, S., et al., on behalf of the Royal College of Obstetricians and Gynaecologists. Management of inherited bleeding disorders in pregnancy. Green-top Guideline No. 71. 2017. 124(8): p. e193-e263. https://doi.org/10.1111/1471-0528.14592

Grainger, J.D., J. Thachil, and A.M.J.B.j.o.h. Will, How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults. 2018. 182(5): p. 621-632. https://doi.org/10.1111/bjh.15409

Nurden, A.T., et al., Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. 2011. 118(23): p. 5996-6005.

Bolton‐Maggs, P.H., et al., A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. 2006. 135(5): p. 603-633. https://doi.org/10.1111/j.1365-2141.2006.06343.x

Fiore, M., et al., Clinical utility gene card for: Glanzmann thrombasthenia. 2012. 20(10): p. 1101-1101. https://doi.org/10.1038/ejhg.2012.151

Soni, P., et al., Triple jeopardy: A case of Glanzmann's thrombasthenia with anti-GPIIb-IIIa antibodies and HPA incompatibility resulting in stillbirth. 2019. 181: p. 141-144. https://doi.org/10.1016/j.thromres.2019.07.022

Kale, A., et al., The use of recombinant factorVIIa in a primigravida with Glanzmann’s thrombasthenia during delivery. 2004. 32(5): p. 456-458. https://doi.org/10.1515/jpm.2004.147

Nurden, A., J.J.H. George, and thrombosis, Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. 2006: p. 987- 1010.

Siddiq, S., A. Clark, and A.J.H. Mumford, A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia. 2011. 17(5): p. e858-e869. https://doi.org/10.1111/j.1365-2516.2011.02516.x

Monte, S. and G.J.B.j.o.a. Lyons, Peripartum management of a patient with Glanzmann’s thrombasthenia using Thrombelastograph®. 2002. 88(5): p. 734-738. https://doi.org/10.1093/bja/88.5.734

Shamsi, T.S., et al., Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature. 2005. 55(11): p. 512.

Nurden, A.T., X. Pillois, and D.A. Wilcox. Glanzmann thrombasthenia: state of the art and future directions. in Seminars in thrombosis and hemostasis. 2013. NIH Public Access. https://doi.org/10.1055/s-0033-1353393

Nurden, A.T.J.O.j.o.r.d., Glanzmann thrombasthenia. 2006. 1(1): p. 10. https://doi.org/10.1186/1750-1172-1-10

Vadasz, B., et al., Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. 2015. 2(2): p. 173-185. https://doi.org/10.1016/j.gendis.2015.02.003

Léticée, N., et al., Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb–IIIa: Is there a foetal risk? 2005. 121(2): p. 139-142. https://doi.org/10.1016/j.ejogrb.2005.02.011

Sherer, D.M. and R.J.A.j.o.p. Lerner, Glanzmann's thrombasthenia in pregnancy: a case and review of the literature. 1999. 16(06): p. 297-301. https://doi.org/10.1055/s-2007-993875

Madgudapathi, C., S. Kannan, and D.J.J.C.C.R. Giri, Glanzmann’s thrombasthenia complicating pregnancy. 2012. 2: p. 142-142. https://doi.org/10.4172/2165-7920.1000142

Capuzzo, E., et al., Glanzmann's thrombasthenia and puerperium. 1997. 57(3): p. 313-314. https://doi.org/10.1016/s0020-7292(97)02908-1

Nordisk, N.J.F.A.O., Novoseven Coagulation Factor VIIA (Recombinant). 1999: p. 1-24.

Douri, M.A., et al., Effect of Recombinant Activated Factor VII in the Management of Severe Uncontrolled Bleeding During Cardiac Surgery. 2001. 3(5): p. 24-29. https://doi.org/10.1111/j.1778- 428x.2001.tb00046.x

Joo, Y.M., et al., Successful hemostasis by the use of recombinant factor VIIa in uncontrolled active hemorrhage of multiple trauma patients. 2011. 22(1): p. 22-29.

Ahonen, J. and R.J.B.J.o.A. Jokela, Recombinant factor VIIa for life-threatening post-partum haemorrhage. 2005. 94(5): p. 592-595. https://doi.org/10.1093/bja/aei094

Raivio, P., R. Suojaranta-Ylinen, and A.H.J.T.A.o.t.s. Kuitunen, Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. 2005. 80(1): p. 66-71. https://doi.org/10.1016/j.athoracsur.2005.02.044

O’Connell, K.A., et al., Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. 2006. 295(3): p. 293-298. https://doi.org/10.1001/jama.295.3.293

Downloads

Published

2020-12-25

Issue

Vol. 8 No. 1

Section

Articles